Puma Biotechnology | Capitale Di Prestito



Loan Capital Cambiamento Data
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 54.01B 2.54B 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Daiichi Sankyo JPY 100.93B 95M 2025-03
Exelixis USD 0 0 2025-04
Gilead Sciences USD 24.9B 3.46B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
MacroGenics USD 0 0 2024-12
Moderna USD 35M 4M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Takeda JPY 3.97T 738.36B 2025-03
TG Therapeutics USD 244.43M 271K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Puma Biotechnology Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.